ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

C3 Glomerulopathy Secondary to Complement Factor H Inhibition by Monoclonal Kappa Light Chains.

C. Blosser,1 Y. Zhang,2 T. Dhawale,3 C. Johnson,1 P. Hendrie,3 R. Smith.2

1Medicine, University of Washington, Seattle, WA
2Medicine & Surgery, University of Iowa, Iowa City, IA
3Medicine, Seattle Cancer Care Alliance, Seattle, WA.

Meeting: 2016 American Transplant Congress

Abstract number: B304

Keywords: Glomerulonephritis, Malignancy, Monoclonal antibodies, Recurrence

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: PTLD/Malignancies: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • De Novo Proliferative Glomerulonephritis with Monoclonal IgG Deposits of the IgG1κ Subtype in a Kidney Allograft: Protocol Biopsy Findings.
  • TNT009 and Its Parental Mouse Monoclonal Antibody TNT003 Target Complement Component C1s and Effectively Block Alloantibody-Induced Classical Complement Pathway Activation – The Preclinical Experience.

Background: Monoclonal gammopathy of renal significance (MGRS) implies a causal relationship between clonal B cell proliferation and renal disease and is associated with high morbidity due to circulating monoclonal immunoglobulins (MIg). A subset of MGRS with dominant glomerular C3 deposition or MGRS-C3 glomerulopathy (C3G) has been reported. Free immunoglobulin light chains (FLCs) are detected in some patients with complement-mediated kidney disease. Here we report the first case of monoclonal IgG κ FLC binding and inhibiting Factor H (FH) regulatory activity leading to C3G.

Case: A 68yr old man with ESRD from MPGN and a history of MGUS (Monoclonal IgG κ 1g/dL in 2010) was evaluated for kidney transplant in 2014. He had low C3 34mg/dl (87-247), normal C4 & C5. Functional complement assays revealed elevated soluble C5b-9 and high FH autoantibody titer (1:400). IgG κ FLCs bind and inhibit FH by ELISA and Cofactor Assay. He received 5 cycles of cyclophosphamide, bortezomib and dexamethasone (CyBorD), normalizing FLCs, complement levels and functional assays.

Discussion: The MGRS-IgG κ FLCs can act as mini-autoantibodies against the N-terminus of FH, impairing cofactor activity. The patient experienced a complete response. Repeat labs and kidney transplant candidacy will be assessed after 3 more cycles of chemotherapy.

Conclusion: Detailed analysis of patients' health prior to transplant can mitigate potential risks, including recurrent C3G. IgG κ FLC causing dysregulation of alternative complement pathway through FH inhibition has not been previously reported. Treatment with appropriate chemotherapy and/or autologous stem cell transplant should be considered for such patients.

CITATION INFORMATION: Blosser C, Zhang Y, Dhawale T, Johnson C, Hendrie P, Smith R. C3 Glomerulopathy Secondary to Complement Factor H Inhibition by Monoclonal Kappa Light Chains. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Blosser C, Zhang Y, Dhawale T, Johnson C, Hendrie P, Smith R. C3 Glomerulopathy Secondary to Complement Factor H Inhibition by Monoclonal Kappa Light Chains. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/c3-glomerulopathy-secondary-to-complement-factor-h-inhibition-by-monoclonal-kappa-light-chains/. Accessed February 26, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.